2021
Marco Prinz
2021 Novo Nordisk Prize recipient: paving the way for novel therapeutic options for brain disorders
When Marco Prinz chose to study microglia after his medical studies, they were the most boring cells in the brain. Twenty-four years later, he is receiving the 2021 Novo Nordisk Prize for his pioneering studies of the crucial roles of these cells in the central nervous system, both in normal brain function and in connection with disease. His groundbreaking results form the basis for new diagnostic and treatment concepts for diseases such as multiple sclerosis and Alzheimer’s.
About Marco Prinz
Marco Prinz
Professor
- 1990–1996 Medical studies, Humboldt University (Charité), Berlin, Germany
- 1997–1998 Postdoctoral Fellow, Max Delbrück Center for Molecular Medicine, Berlin-Buch, Germany
- 1999–2002 Postdoctoral Fellow and Medical Doctor, Institute of Neuropathology, University of Zurich, Switzerland
- 2004 Habilitation at the Medical School, University of Göttingen; Lecturer (“Habilitation”), Consultant (“Facharzt” and “Oberarzt”) for Neuropathology, Institute of Neuropathology, University of Göttingen, Germany
- 2008– Professor (W3) and Director, Institute of Neuropathology, Medical Center, University of Freiburg, Germany
- 2014 Sobek Prize
- 2015 Reinhart-Koselleck Grant
- 2017– Coordinator of the SFB/TRR 167 NeuroMac on myeloid cells in the CNS
- 2018– Highly cited researcher (Clarivate Analytics)
- 2018 Ernst Jung Prize
- 2020 Gottfried Wilhelm Leibniz Prize